AngioDynamics (ANGO) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

AngioDynamics Revenue Highlights


Latest Revenue (Y)

$303.91M

Latest Revenue (Q)

$67.49M

Main Segment (Y)

Med Device

Main Geography (Y)

UNITED STATES

AngioDynamics Revenue by Period


AngioDynamics Revenue by Year

DateRevenueChange
2024-05-31$303.91M-10.28%
2023-05-31$338.75M7.13%
2022-05-31$316.22M8.66%
2021-05-31$291.01M10.17%
2020-05-31$264.16M-26.52%
2019-05-31$359.48M4.41%
2018-05-31$344.29M-1.53%
2017-05-31$349.64M-1.14%
2016-05-31$353.69M-0.92%
2015-05-31$356.97M0.71%
2014-05-31$354.45M3.63%
2013-05-31$342.03M54.21%
2012-05-31$221.79M2.70%
2011-05-31$215.96M-0.04%
2010-05-31$216.03M10.76%
2009-05-31$195.05M17.15%
2008-05-31$166.50M48.36%
2007-05-31$112.23M43.05%
2006-06-03$78.45M30.12%
2005-05-28$60.29M22.90%
2004-05-29$49.05M27.63%
2003-05-31$38.43M24.42%
2002-05-31$30.89M32.06%
2001-05-31$23.39M-

AngioDynamics generated $303.91M in revenue during NA 2024, up -10.28% compared to the previous quarter, and up 84.54% compared to the same period a year ago.

AngioDynamics Revenue by Quarter

DateRevenueChange
2024-08-31$67.49M-4.92%
2024-05-31$70.98M-5.59%
2024-02-29$75.18M-4.92%
2023-11-30$79.07M0.50%
2023-08-31$78.68M-13.61%
2023-05-31$91.07M12.84%
2023-02-28$80.71M-5.52%
2022-11-30$85.43M4.77%
2022-08-31$81.54M-6.28%
2022-05-31$87.00M17.61%
2022-02-28$73.97M-5.51%
2021-11-30$78.28M1.70%
2021-08-31$76.97M0.17%
2021-05-31$76.84M7.95%
2021-02-28$71.18M-2.18%
2020-11-30$72.77M3.64%
2020-08-31$70.22M20.37%
2020-05-31$58.33M-16.41%
2020-02-29$69.78M-0.32%
2019-11-30$70.00M6.00%
2019-08-31$66.04M-31.42%
2019-05-31$96.30M11.53%
2019-02-28$86.34M-5.64%
2018-11-30$91.50M7.22%
2018-08-31$85.34M-3.37%
2018-05-31$88.32M5.33%
2018-02-28$83.85M-3.29%
2017-11-30$86.71M1.52%
2017-08-31$85.41M-1.73%
2017-05-31$86.91M1.53%
2017-02-28$85.60M-3.85%
2016-11-30$89.03M1.06%
2016-08-31$88.10M-5.65%
2016-05-31$93.37M6.85%
2016-02-29$87.38M-2.07%
2015-11-30$89.23M6.61%
2015-08-31$83.70M-7.91%
2015-05-31$90.90M4.97%
2015-02-28$86.60M-6.03%
2014-11-30$92.15M5.52%
2014-08-31$87.33M-7.16%
2014-05-31$94.06M6.66%
2014-02-28$88.19M-0.48%
2013-11-30$88.62M6.03%
2013-08-31$83.58M-7.17%
2013-05-31$90.03M10.37%
2013-02-28$81.57M-6.25%
2012-11-30$87.01M4.32%
2012-08-31$83.41M44.58%
2012-05-31$57.69M11.87%
2012-02-29$51.57M-11.24%
2011-11-30$58.10M6.74%
2011-08-31$54.43M-3.19%
2011-05-31$56.22M2.88%
2011-02-28$54.65M2.39%
2010-11-30$53.37M3.62%
2010-08-31$51.51M-14.55%
2010-05-31$60.28M15.46%
2010-02-28$52.21M-2.34%
2009-11-30$53.46M6.72%
2009-08-31$50.09M-5.16%
2009-05-31$52.82M6.82%
2009-02-28$49.45M2.03%
2008-11-30$48.46M9.34%
2008-08-31$44.32M-5.20%
2008-05-31$46.75M14.80%
2008-02-29$40.73M-

AngioDynamics generated $67.49M in revenue during Q1 2025, up -4.92% compared to the previous quarter, and up 74.11% compared to the same period a year ago.

AngioDynamics Revenue Breakdown


AngioDynamics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMay 24May 22May 21May 20May 19
Med Device$197.51M$237.50M---
Med Tech$106.40M$78.72M---
Endovascular Therapies--$135.08M--
Oncology Surgery--$54.62M$57.15M-
Access---$94.30M$94.73M
Peripheral Vascular---$112.71M-

AngioDynamics's latest annual revenue breakdown by segment (product or service), as of May 24: Med Device (64.99%), and Med Tech (35.01%).

Quarterly Revenue by Product

Product/ServiceAug 24May 24Feb 24Nov 23Aug 23May 22Feb 22Nov 21Aug 21
Med Device$39.52M$41.64M$49.34M$53.71M$52.82M$64.40M$54.36M$59.39M$59.35M
Med Tech$27.97M$29.34M$25.84M$25.36M$25.86M$22.60M$19.61M$18.89M$17.62M

AngioDynamics's latest quarterly revenue breakdown by segment (product or service), as of Aug 24: Med Device (58.56%), and Med Tech (41.44%).

AngioDynamics Revenue Breakdown by Country

Annual Revenue by Country

CountryMay 24May 23May 22May 21May 20
International$52.43M----
UNITED STATES$251.49M$84.33M$146.88M$121.43M$98.97M
Non-US-$12.36M$14.04M$13.65M$13.74M

AngioDynamics's latest annual revenue breakdown by geography, as of May 24: UNITED STATES (82.75%), and International (17.25%).

Quarterly Revenue by Country

CountryAug 24May 24Feb 24Nov 23Aug 23May 23Feb 23Nov 22Aug 22May 22Feb 22Nov 21Aug 21May 21Feb 21Nov 20Aug 20May 20Feb 20Nov 19
UNITED STATES$59.48M$60.74M$62.34M$64.00M$64.40M$22.96M$20.38M$20.55M$20.44M$21.87M$19.48M$20.70M$20.48M$34.23M$29.53M$30.69M$26.98M$18.90M$26.79M$27.60M
Non-US$8.01M$12.84M$15.07M$14.28M$3.54M$2.49M$3.95M$2.38M$4.86M$3.95M$4.37M$4.48M$3.84M$3.72M$3.21M$2.88M$3.19M$3.76M$3.55M-

AngioDynamics's latest quarterly revenue breakdown by geography, as of Aug 24: UNITED STATES (88.13%), and Non-US (11.87%).

AngioDynamics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
COOCooper Companies$3.59B$1.00B
ATRAptarGroup$3.49B$910.06M
NVSTEnvista$2.57B$623.60M
ICUIICU Medical$2.26B$596.46M
HAEHaemonetics$1.31B$336.17M
MMSIMerit Medical Systems$1.26B$338.00M
ATRCAtriCure$399.25M$116.27M
ANGOAngioDynamics$303.91M$67.49M
NSTGNanoString$127.26M$48.09M
AKYAAkoya Biosciences$96.63M$23.16M
KRMDKORU Medical Systems$28.52M$8.20M
ATRIAtrion-$48.77M

ANGO Revenue FAQ


AngioDynamics's yearly revenue for 2024 was $303.91M, representing a decrease of -10.28% compared to 2023. The company's yearly revenue for 2023 was $338.75M, representing an increase of 7.13% compared to 2022. ANGO's yearly revenue for 2022 was $316.22M, representing an increase of 8.66% compared to 2021.

AngioDynamics's quarterly revenue for Q1 2025 was $67.49M, a -4.92% decrease from the previous quarter (Q4 2024), and a -14.22% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $70.98M, a -5.59% decrease from the previous quarter (Q3 2024), and a -22.06% decrease year-over-year (Q4 2023). ANGO's quarterly revenue for Q3 2024 was $75.18M, a -4.92% decrease from the previous quarter (Q2 2024), and a -6.85% decrease year-over-year (Q3 2023).

AngioDynamics's revenue growth rate for the last 3 years (2022-2024) was -3.89%, and for the last 5 years (2020-2024) was 15.05%.

AngioDynamics's revenue streams in y 24 are Med Device, and Med Tech. Med Device generated $197.51M in revenue, accounting 64.99% of the company's total revenue, down -16.84% year-over-year. Med Tech generated $106.4M in revenue, accounting 35.01% of the company's total revenue, up 35.17% year-over-year.

For the fiscal year ending May 24, the largest source of revenue of AngioDynamics was Med Device. This segment made a revenue of $197.51M, representing 64.99% of the company's total revenue.